6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione has been researched along with silver in 1 studies
Studies (6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione) | Trials (6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione) | Recent Studies (post-2010) (6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione) | Studies (silver) | Trials (silver) | Recent Studies (post-2010) (silver) |
---|---|---|---|---|---|
49 | 0 | 28 | 29,477 | 303 | 18,251 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Deng, B; Luo, Z; Mo, G; Mo, K; Qin, D; Wu, Y | 1 |
1 other study(ies) available for 6-(n-(4-aminobutyl)-n-ethyl)amino-2,3-dihydrophthalazine-1,4-dione and silver
Article | Year |
---|---|
Dual-potential electrochemiluminescence cytosensor based on a metal-organic framework and ABEI-PEI-Au@AgNPs for the simultaneous determination of phosphatidylserine and epidermal growth factor receptors on an apoptotic cell surface.
Topics: Apoptosis; Biosensing Techniques; Cell Membrane; EGF Family of Proteins; ErbB Receptors; Luminescent Measurements; Metal Nanoparticles; Metal-Organic Frameworks; Phosphatidylserines; Reproducibility of Results; Silver | 2023 |